ArrowArtboardCreated with Sketch.Title ChevronTitle ChevronIcon FacebookIcon LinkedinIcon Mail ContactPath LayerIcon MailPositive ArrowIcon Print
COVID vaccines

Japan's Shionogi booster delivers similar results to Pfizer: study

Deliveries of COVID vaccine to start as early as May after trial success

A local resident receives a COVID-19 booster shot at a Tokyo mass vaccination center.    © Reuters
SOSUKE KARINO, Nikkei staff writer | Japan

OSAKA -- Japanese drugmaker Shionogi's COVID-19 vaccine candidate was found to be as effective as Pfizer shots as a booster in a late-stage clinical trial, the company announced Friday.

"We saw extremely positive results, and we hope to accelerate development," President and CEO Isao Teshirogi told reporters.

Read Next

Latest On COVID vaccines

Sponsored Content

About Sponsored Content This content was commissioned by Nikkei's Global Business Bureau.

Discover the all new Nikkei Asia app

  • Take your reading anywhere with offline reading functions
  • Never miss a story with breaking news alerts
  • Customize your reading experience

Nikkei Asian Review, now known as Nikkei Asia, will be the voice of the Asian Century.

Celebrate our next chapter
Free access for everyone - Sep. 30

Find out more

By continuing to browse this website, you accept cookies which are used for several reasons such as personalizing content/ads and analyzing how this website is used. Please review our Cookie Policy to learn how you can update your cookie settings.

Accept & Continue Close